Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease. [electronic resource]
- Journal of drug targeting 02 2018
- 150-161 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't